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Mitochondria are highly mobile and dynamic organ-
elles that continually fuse and divide. These pro-
cesses allow mitochondria to exchange contents,
including mitochondrial DNA (mtDNA). Here we
examine the functions of mitochondrial fusion in
differentiated skeletal muscle through conditional
deletion of the mitofusins Mfn1 and Mfn2, mitochon-
drial GTPases essential for fusion. Loss of themitofu-
sins causes severe mitochondrial dysfunction, com-
pensatory mitochondrial proliferation, and muscle
atrophy. Mutant mice have severe mtDNA depletion
in muscle that precedes physiological abnormalities.
Moreover, the mitochondrial genomes of the mutant
muscle rapidly accumulate point mutations and dele-
tions. In a related experiment, we find that disruption
of mitochondrial fusion strongly increasesmitochon-
drial dysfunction and lethality in a mouse model with
high levels of mtDNA mutations. With its dual func-
tion in safeguarding mtDNA integrity and preserving
mtDNA function in the face of mutations, mitochon-
drial fusion is likely to be a protective factor in human
disorders associated with mtDNA mutations.
INTRODUCTION
Mitochondrial fusion and fission have emerged as important
processes that govern mitochondrial function from yeast to
mammals (Detmer and Chan, 2007a; Suen et al., 2008; Okamoto
and Shaw, 2005; Hoppins et al., 2007). In mammalian cells, three
large GTPases are important for mitochondrial fusion, which
requires the coordinated fusion of the outer and inner mem-
branes. The mitofusins, Mfn1 and Mfn2, are located on the mito-
chondrial outer membrane and are involved in early steps in280 Cell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc.membrane fusion (Koshiba et al., 2004; Meeusen et al., 2004;
Song et al., 2009). The dynamin-related protein OPA1 is associ-
ated with the inner membrane and is essential for inner
membrane fusion (Song et al., 2009; Meeusen et al., 2006).
In addition to its well-recognized function of controlling mito-
chondrial morphology (Bleazard et al., 1999; Chen et al., 2003;
Sesaki and Jensen, 1999), mitochondrial fusion clearly protects
mitochondrial function (Detmer and Chan, 2007a). Mutations in
Mfn2 and OPA1 (Alexander et al., 2000; Delettre et al., 2000;
Zuchner et al., 2004) cause two neurodegenerative diseases—
Charcot-Marie-Tooth type 2A and dominant optic atrophy,
respectively. Neurodegeneration is also prominent in mice with
a targeted mutation in Mfn2 (Chen et al., 2007). Cells that lack
mitochondrial fusion have a severe defect in respiratory capacity
(Chen et al., 2005). Their fragmented mitochondria become
functionally divergent, resulting in heterogeneity in membrane
potential and mitochondrial DNA (mtDNA) nucleoids, which
encode components of the electron transport chain. These
results have led to a model in which mitochondrial fusion
protects mitochondrial function by enabling content mixing
(Detmer and Chan, 2007a; Chen et al., 2007).
Because of this content mixing, it has been hypothesized that
mitochondrial fusionmay be involved in the ability of human cells
to tolerate high levels of pathogenic mtDNA (Nakada et al., 2001,
2009). A distinguishing feature of mitochondrial genetics is that
most mtDNA mutations are recessive and must accumulate to
high proportions before an effect on oxidative phosphorylation
is observed (DiMauro and Schon, 2003; Taylor and Turnbull,
2005). Depending on the mutation, heteroplasmic cells (contain-
ing both mutant and wild-type mtDNA) can accumulate up to
60%–90% pathogenic mtDNA molecules without a noticeable
decline in respiratory activity (Rossignol et al., 2003; Chomyn,
1998). In both cultured cells andmousemodels, cells engineered
to contain a mixture of wild-type and pathogenic mtDNA are
protected from dysfunction until a high threshold of pathogenic
mtDNA is breached (Nakada et al., 2009; Ono et al., 2001). These
observations have led to the proposal that intermitochondrial
Table 1. Physiological Measurements on Seven- to Eight-Week-Old MLC/dm Mice
Measurement Double-Mutant Control p Value
Weight (females) 11 ± 2.6 g, n = 2 23 ± 2.1 g, n = 6 < 0.0001
Weight (males) 10 ± 2.4 g, n = 11 30 ± 3.6 g, n = 11 < 0.0001
Body temperature 35 ± 1.1C, n = 10 37 ± 0.3C, n = 20 < 0.0001
Nonfasting blood glucose 50 ± 14 mg/dL, n = 2 143 ± 13 mg/dL, n = 7 < 0.0001
Fasting blood glucose 26 ± 2.8 mg/dL, n = 2 78 ± 12 mg/dL, n = 10 = 0.0002
Resting serum lactate 5.7 ± 1.7 mmol/l, n = 7 3.9 ± 1.2 mmol/l, n = 9 = 0.02
Post-exercise lactate 9.5 ± 2.3 mmol/l, n = 5 4.7 ± 0.65 mmol/l, n = 5 = 0.002
Measurements are given as value ± standard deviation. p values were calculated using the unpaired t test. Controls are mixed genotype littermates of
double-mutant animals. The number of animals (n) for each measurement is indicated.mixing in heteroplasmic cells might underlie the functional
complementation of pathogenic mtDNA genomes (Nakada
et al., 2001, 2009). However, the proposed role of mitochondrial
fusion in functional complementation remains to be experimen-
tally tested.
Other fundamental issues concerning mitochondrial fusion
remain to be explored. Most studies on mammalian mitochon-
drial dynamics have been limited to cultured cells and neurons
(Detmer and Chan, 2007a; Suen et al., 2008). These studies
show that mitochondrial fusion is highly associated with mito-
chondrial transport along the cytoskeleton because mitochon-
dria fuse when they collide end-to-end or end-to-side. However,
little is known about the role of mitochondrial dynamics in most
tissues in vivo, including skeletal muscle fibers, which are highly
metabolically active and are often affected in diseases of
mitochondrial dysfunction. Elegant ultrastructural studies have
documented that mitochondria in skeletal muscle are tightly
packed and arranged in a stereotypic manner in relation to the
sarcomeric unit (Ogata and Yamasaki, 1997). This unique orga-
nization and apparently limited mobility raises the issue of
whether mitochondrial dynamics is important in this cell type.
To address these issues, we examined mice lacking mitofusin
function in skeletal muscle and found that these mice develop
a lethal mitochondrial myopathy. In addition, we found that mito-
chondrial fusion protects mtDNA function through several
distinct mechanisms. It maintains mtDNA levels, preserves
mtDNA fidelity, and enables cells to tolerate high levels ofmtDNA
mutations.
RESULTS
A Role of Mitofusins Mfn1 and Mfn2 in Skeletal Muscle
Given the unique arrangementofmitochondria in skeletalmuscle,
we examined whether mitochondrial fusion plays an important
role in this cell type. Using MLC-Cre transgenic mice, we specif-
ically disrupted the mitochondrial fusion genesMfn1 andMfn2 in
skeletal muscle (Bothe et al., 2000). The MLC1f promoter that
drives Cre recombinase is well-characterized to express in differ-
entiated fast-twitchmuscle cells andnot inmyocytes (Lyonsetal.,
1990). Surprisingly, such double-mutant mice (MLC-Cre/dm) are
severely runted, reaching only 30%–50% the weight of control
littermates (Table 1) beforedyingby6–8weeksof age. In contrast,
mice of othergenotypic combinations (includingMfn1/Mfn2+/
andMfn1+/Mfn2/) survive and grow to normal size.MLC-Cre/dm mice show severe physiological aberrations.
They display low blood glucose levels under fasting and nonfast-
ing conditions and reduced body temperatures (Table 1). More-
over, we found high levels of lactate in the serum ofMLC-Cre/dm
mice, most pronounced after an exercise regiment but also
under resting conditions. These profound metabolic aberrations
suggest a rapid turnover of glucose without adequate energy
production, as would result from the predominant use of glycol-
ysis instead of oxidative phosphorylation.
Mitochondrial Defects in Mitofusin-Deficient Muscle
On gross examination of muscle, it is readily apparent that the
MLC-Cre/dm mice have smaller muscles that are deeper red
than control muscles (Figure 1A), suggesting an increase in mito-
chondrial mass. This interpretation is confirmed by electron
microscopy (EM) of tibialis anterior (TA) muscle, which is com-
posed of predominantly fast-twitch fibers. On longitudinal
sections, wild-type 7-week-old skeletal muscle displays tightly
juxtaposed arrays of myofibrils that are extremely uniform and
precisely aligned (Figure 1C). Consistent with previous ultra-
structural studies of muscle fiber architecture (Ogata and
Yamasaki, 1997), the mitochondria typically reside in pairs, posi-
tioned on either side of the Z-disc in each I band. In contrast, the
mitochondria in 7-week MLC-Cre/dm muscle are fragmented
into round spheres, as has been found in other cells lackingmito-
chondrial fusion (Chen et al., 2003, 2007; Chen and Chan, 2005).
In addition, there is massive accumulation of mitochondria
that are tightly packed throughout the space between myofibrils
(Figure 1D). These aggregates of mitochondria fill the interfibrillar
space and disrupt the alignment of myofibril arrays. We also
observed proliferation of mitochondria in double-mutant
4-week-old muscle, although the increase is less extensive,
and regions with normal mitochondrial content are preserved
(Figure S1 available online). Highly pronounced accumulations
of mitochondria are likewise present in the subsarcolemmal
space (Figures 1I and 1J), similar to that observed in ragged-
red fibers of mitochondrial myopathies caused by mtDNA muta-
tions (DiMauro and Schon, 2003). Furthermore, both interfibrillar
and subsarcolemmal mitochondria in mutant muscle show
classic ultrastructural signs of dysfunction: they are swollen
and contain few of the densely packed cristae membranes char-
acteristic of wild-type mitochondria (Figures 1E and 1F). Quanti-
fication of the micrographs indicates that in MLC-Cre/dm
muscle, the mitochondria occupy several-fold more area thanCell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc. 281
Figure 1. Mitochondrial Defects in Seven-Week-
Old MLC-Cre/dm Muscle
(A) Whole-mount gastrocnemius muscles. The double-
mutant muscle (right) is smaller and deeper red.
(B) Quantification of mitochondrial area in muscle of the
indicated genotypes. The area occupied by mitochondria
was measured from at least 10 representative EM fields
and normalized to the area occupied by mitochondria in
wild-type muscle. Asterisks (p < 0.0003, unpaired t test)
indicate significant changes, and error bars indicate
standard deviations.
(C–J) Electron microscopy of tibialis anterior (TA) longitu-
dinal sections. Labels: s, length of sarcomere; Z, Z-disc;
m, mitochondria. (C, E, and I) Wild-type. (D, F, and J)
Mfn double mutant. (G) Mfn1/ Mfn2+/. (H) Mfn1+/
Mfn2/. (I and J) Subsarcolemmal mitochondria. Scale
bars: 0.5 mm in C–F, I, and J; 1 mm in G and H.
See also Figure S1.in wild-typemuscle (Figure 1B). In contrast, muscles carrying just
one Mfn allele show much milder histological defects (Figures
1B, 1G, and 1H), with occasional patches of abnormal mitochon-
dria particularly evident in Mfn1/ Mfn2+/ muscle (Figure 1G).
Given the physiological and ultrastructural evidence for
mitochondrial dysfunction, we used histochemical staining for
cytochrome c oxidase (COX, complex IV, brown stain) and
succinate dehydrogenase (SDH, complex II, blue stain) activity
to directly assess the function of respiratory complexes. In
1- and 2-week-old wild-type mice, the muscle sections show
uniform COX staining of all the muscle fibers (Figures 2A and282 Cell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc.2C). Over the next several weeks, this gradually
matures into the brown checkerboard appear-
ance of adult muscle, due to the differentiation
of specific muscle fiber types with varying
mitochondrial activity (Figures 2E and 2G). In
MLC-Cre/dm muscle, the staining pattern is
normal at week 1, but a mildly abnormal pattern
emerges at week 2 with the appearance of
some fibers that stain faintly blue, indicating
increased SDH and low COX activity (Figure 2D,
arrows). This abnormal histological pattern
becomes highly pronounced at 4 and 7 weeks,
at which time many deeply blue fibers are
apparent (Figures 2F and 2H). In human mito-
chondrial encephalomyopathies, this charac-
teristic blue histological pattern is often found
in cases of respiratory dysfunction due to
mtDNA defects (DiMauro and Schon, 2003;
Taylor and Turnbull, 2005), because SDH
activity is encoded solely by the nuclear
genome, whereas COX activity is dependent
on the mitochondrial genome. The increased
SDH staining is consistent with the increased
mitochondrial accumulation observed by EM
(Figures 1B, 1D, and 2J). In addition, double-
mutant muscle fibers have notably smaller
diameters at 4 and 7 weeks. This small fiber
size accounts for the overall decreased musclesize because no reduction in fiber number was found (data not
shown). In contrast, Mfn1/ Mfn2+/ and Mfn1+/ Mfn2/
muscles demonstrate normal COX/SDH staining patterns,
normal fiber size, and no systemic indicators of respiratory
deficiency (Figures 2I and 2J). Therefore, the severe defects
found in MLC-Cre/dm mice are not due to a specific function
of Mfn2 versus Mfn1.
Loss of mitofusins also resulted in a marked shift in the
composition of skeletal muscle fiber types. MLC-Cre/dm tibialis
anterior muscles show an increase in the proportion of fibers
positive for myosin heavy chain 2A, a marker for oxidative type
Figure 2. TemporalAnalysisofRespiratoryDeficiency inMLC-Cre/dm
Muscle
Transverse sections of TA muscle were stained histochemically for COX
(brown) and SDH (blue) activity. (A, C, E, and G) Wild-type muscle. (B, D, F,
and H) Double-mutant muscle. Blue staining is indicative of mitochondrial
dysfunction. Note the initial appearance of faintly blue fibers in (D) (arrows)
and deeply blue fibers in (F) and (H). The ages of the samples are indicated.
(I and J) Genotypes and age of the muscles are indicated. 4003magnification.
See also Figure S2.IIA fibers, and a corresponding decrease in the proportion of
fast-twitch type IIB fibers (Figure S2). These results are consis-
tent with reports that mitochondrial biogenesis can drive muscle
fiber type switching (Arany et al., 2007; Lin et al., 2002).
Mitofusins Are Important for mtDNA Stability
and Fidelity
Given the histological and physiological features of mitochon-
drial myopathy in MLC-Cre/dm mice, we investigated the
relationship between mitochondrial fusion and mtDNA copynumber. Remarkably, we found that 7- to 8-week-old muscle
from double-mutant mice contains only 250 copies of mtDNA
per nuclear genome, whereas muscle from age-matched con-
trols contains 3500 copies of mtDNA per nuclear genome
(Figure 3A). Mice with single alleles of either Mfn1 or Mfn2
show normal levels of mtDNA at 7–8 weeks (Figure 3A) and later
(Figure S3A).
To determine the temporal relationship between the mtDNA
depletion and the muscle fiber defects, we analyzed mtDNA
levels in younger MLC-Cre/dm muscle (Figure 3B). Even at the
earliest time point, 1 week of age, we measured a significantly
lower level of mtDNA in MLC-Cre/dm muscle compared to
control littermates. The discrepancy in mtDNA levels between
MLC-Cre/dm and wild-type muscle enlarges over the next
several weeks due to the rapid increase in mtDNA content in
wild-type muscle. In contrast, mtDNA in mutant muscle fails to
expand during postnatal development. Because this mtDNA
depletion becomes evident prior to histological evidence for
gross mitochondrial dysfunction (Figure 2), it is likely that
reduced mtDNA levels in the mutants underlie, at least in part,
the muscle pathology observed later.
Wemade similar observations of mtDNA loss inmouse embry-
onic fibroblasts (MEFs) that lack bothMfn1 andMfn2 (Figure 3C),
consistent with the impaired respiratory capacity of these cells
(Chen et al., 2005). In contrast, MEFs with only a partial defect
in fusion (Mfn1/ or Mfn2/ cells) harbor normal levels of
mtDNA (Figure 3C) and respire normally (Chen et al., 2005).
Importantly, overexpression of either Mfn1 or Mfn2 in Mfn-
double null MEFs rapidly restores mtDNA to wild-type levels
(Figure 3D), again emphasizing that the shared function of mito-
chondrial fusion byMfn1 andMfn2 is responsible for the defects.
Moreover, we found that OPA1 null cells, which are deficient for
fusion of the inner mitochondrial membrane, but proficient for
outer membrane fusion (Song et al., 2009), also display mtDNA
depletion (Figure 3C), suggesting that lack of mixing of thematrix
compartment is ultimately responsible for loss of mtDNA in
fusion-deficient cells.
To further explore the connection between mitochondrial
fusion and mtDNA, we interrogated the fidelity of the mitochon-
drial genome by screening mtDNA for point mutations and dele-
tions. We found that muscle from 7- to 8-week-old MLC-Cre/dm
mice harbors a 5-fold increase in mtDNA point mutations (Fig-
ure 4A) and a 14-fold increase in deletions (Figure 4C) compared
to wild-type animals. We confirmed both of thesemeasurements
by interrogating additional loci in the mitochondrial genome
(Figures 4B and 4D). Most deletions occurred between short
homologous repeats in both double-mutant and wild-type
tissue, whereas there was a shift in the spectrum of single
base pair substitutions in double-mutant mice (Figures S4B
and S4C).
Because mitochondrial mutations accumulate with age
(Vermulst et al., 2007, 2008a), we also examined mtDNA from
older animals carrying single alleles of Mfn1 or Mfn2. Remark-
ably, we found that muscle tissue from 8- to 13-month-old
Mfn1/ Mfn2+/ mice exhibits an 80-fold increase in mtDNA
deletions (2.3 3 105/genome) compared to control muscle
(2.8 3 107/genome) (Figure 4C). This increase was confirmed
by analysis at an independent site (Figure 4D). However, weCell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc. 283
Figure 3. Quantitative Analysis of mtDNA from
Muscle and MEFs
(A) Analysis of mtDNA copy number per nuclear genome in
7- to 8-week TA muscle. Controls include wild-type,
Mfn1+/, and Mfn2+/ littermates of the double mutants.
p = 0.0002.
(B) Temporal analysis of mtDNA depletion in double-
mutant TA muscle. Ages of the samples are indicated.
p < 0.008. Legend indicates genotypes for (A) and (B).
(C) Mitochondrial copy number in MEFs. Genotypes are
indicated. p < 0.0001.
(D) Restoration of mtDNA levels in Mfn-double null cells.
mtDNA levels were measured in mutant cells infected
with retrovirus expressing mito-DsRed (mock), Mfn1, or
Mfn2. Mitochondria were analyzed 2 and 4 weeks after
infection. p < 0.0001. In all panels, asterisks denote statis-
tically significant changes from control, and error bars indi-
cate standard deviations from 3–5 animals or experiments.
To obtain the mtDNA level for a single DNA sample, quan-
titative PCR was performed in quadruplicate. p values
were obtained from unpaired t tests.
See also Figure S3.found no significant change in the frequency of point mutations
or mtDNA copy number ofMfn1/Mfn2+/ orMfn1+/Mfn2/
muscle (Figures S3A and S4A), suggesting that the mechanism
underlying the generation of mtDNA deletions is more sensitive
to a reduction in mitochondrial fusion.
To further confirm this finding of increased mtDNA deletions
in a genome-wide, unbiased manner, we analyzed with Solexa
sequencing mtDNA from 10-month wild-type and Mfn1/
Mfn2+/ muscle. For each sample, we obtained 75-nucleotide
sequence reads that, in aggregate, cover 367.5 and 442.5 million
base pairs of mtDNA. Both ends of each sequence read were
mapped onto the mtDNA genome, and sequences with ends
that mapped to different locations were selected as candidates
for deletions. To minimize the chances of artifactual deletions,
we only considered deletions that were identified by four or
more independent sequence reads (Figure 4E). In wild-type
muscle, we found no such deletions. In contrast, the Mfn1/
Mfn2+/ sample contained nine distinct deletions that were iden-
tified by 62 independent sequence reads, and therefore repre-
sent 62 deletion events. In each case, the breakpoint junction
occurred between repeats of 6–14 nucleotides (Table S1), in284 Cell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc.agreement with our earlier sequence analysis
of deletions breakpoints (Figure S4C). These
nine deletions may comprise particularly vulner-
able regions in themtDNA genome of mitofusin-
deficient mice.
Previous results indicate that fusion-defective
cells have mitochondrial populations that are
heterogeneous for membrane potential and
the presence of mtDNA nucleoids (Chen et al.,
2005, 2007). To extend this finding, we exam-
inedwhetherMfn-double null cells have agener-
alized heterogeneity in protein content. An
unbalanced mitochondrial proteome could
lead to mtDNA instability because precise
stoichiometries of proteins involved in mtDNAmetabolism are likely to be important for mtDNA stability
and fidelity. Therefore, we quantitatively analyzed wild-type and
Mfn-double null MEFs immunostained for cytochrome c and
hsp60, two abundant mitochondrial proteins (Figures S3B
and S3C). In themutant MEFs, the signal intensity ratios for cyto-
chrome c versus hsp60 showed substantially greater variance
within the mitochondrial population than in wild-type cells
(Figures S3D and S3E). This increased variance was highly
significant and resulted in lower correlation coefficients for the
two fluorophores in double-mutant MEFs (p = 0.0001, n = 10).
Similar heterogeneity was found upon expression of three
fluorescent proteins to the mitochondrial matrix (data not
shown). These observations imply that mitochondrial proteomes
may become unbalanced in the absence of content mixing.
Synthetic Lethality between an Error-Prone mtDNA
Polymerase and Loss of Mfn1
We expanded our study to examine a separate issue concerning
the relationship between mitochondrial dynamics and mtDNA
mutations. It has been proposed that mitochondrial fusion might
underlie the remarkable ability of mammalian cells to tolerate
Table 2. Survival of Mice Carrying the PolgAD257A Allele in an
Mfn1-Deficient Background
PolgA
Genotype
Mfn1
Genotype
Actual
Number
of Mice
Actual
Frequency
(%)
Expected
Frequency
(%)
+/+ +/+ 48 7 6.25
+/+ +/ 81 12 12.5
+/+ / 31 5 6.25
D257A/+ +/+ 99 15 12.5
D257A/+ +/ 207 32 25
D257A/+* / 51 8 12.5
D257A/D257A +/+ 34 5 6.25
D257A/D257A +/ 102 16 12.5
D257A/D257A** / 1 0 6.25
Mice of the indicated genotypes are tabulated. A Chi-square test
was used to compare observed and expected populations. *p = 0.0003,
**p < 0.0001.
Figure 4. Quantitative Analysis of mtDNA Mutations
(A–D) Quantification of mtDNAmutations in TAmuscle by the randommutation
capture assay. Legend for genotypes applies to panels (A)–(D). Error bars
indicate standard deviations from 3–5 animals. Asterisks denote statistically
significant changes from control. p values were obtained from unpaired t tests.
(A and B) Quantification of point mutation frequency per base pair at two
independent sites. p = 0.03 in (A); p = 0.05 in (B). (C and D) Quantification
of deletion frequency per mtDNA genome at two independent sites. In (C),
p = 0.01 for young muscle (7–8 weeks), and p = 0.02 for old muscle
(8–13months). In (D), p = 0.0003 for youngmuscle, and p = 0.04 for oldmuscle.
In total, approximately 250 million base pairs were screened for point
mutations, and 700 million genomes for deletion.
(E) Tabulation of mtDNA deletion events from Solexa sequencing of mtDNA
from 10-month skeletal muscle of the indicated genotypes. ‘‘Breakpoint
repeat’’ indicates the number of deletions involving direct repeats of 6–14
base pairs.
See also Figure S4 and Table S1.high loads of pathogenic mtDNA (Nakada et al., 2001, 2009). To
test this idea, we generatedMfn1/mice carrying homozygous
alleles of PolgAD257A. The PolgAD257A knockin allele encodes
a mitochondrial DNA polymerase with a deficient proofreading
domain, causing cells to accumulate mtDNA mutations at anaccelerated rate (Kujoth et al., 2005; Trifunovic et al., 2004).
Remarkably, whereas single mutants for either Mfn1 or PolgA
survivewell into adulthood, the combination of the twomutations
leads to a synthetic neonatal lethality (Table 2). Moreover,
PolgAD257A heterozygous mice, which also have an increased
mutation burden (Vermulst et al., 2007), show reduced viability
in the absence of Mfn1 as well. The synthetic lethality of
PolgAD257A/D257A Mfn1/mice is not due to an increased muta-
tion rate because we detected no significant difference in muta-
tion frequency between PolgAD257A/D257A and PolgAD257A/D257A
Mfn1/ embryos (Figure S5). It would be interesting to test for
a similar synthetic interaction between PolgAD257A and deletion
of Mfn2. However, this interaction is more difficult to assess
because loss of Mfn2 causes a severe neurodegenerative
disorder that leads to early lethality (Chen et al., 2007).
To examine this synergism at a cellular level, we established
MEFs and measured their respiratory capacity and ATP produc-
tion. Oxygen polarography demonstrated a profound decrease
in the endogenous (4.5% of wild-type) and maximum rates
(3.7% of wild-type) of oxygen consumption in PolgAD257A/D257A
Mfn1/ cells compared to controls (Figure 5A). These oxygen
consumption rates were tightly correlated with kinetic measure-
ments of ATP production (Figure 5B), with PolgAD257A/D257A
Mfn1/ cells producing only 2.7% the amount of ATP present
in wild-type cells. To determine whether specific segments of
the respiratory chain are affected, we measured substrate-
driven oxygen consumption rates. The most profound defect
was found in respiratory complex I (20-fold reduction), with
less severe reductions in complexes III (4-fold) and IV (2-fold)
(Figure 5C). The severe reduction in complex I is likely to be
largely responsible for the overall respiratory decline because
the majority of the respiration in these cells occurs via complex
I and is sensitive to the complex I inhibitor rotenone. The severity
of the complex I defect in PolgAD257A/D257A Mfn1/ cells may
reflect the fact that seven mtDNA-encoded subunits are present
in complex I, far more than for any of the other respiratory
complexes. Complex I is therefore more likely than the other
complexes to be inactivated by an mtDNA mutation due toCell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc. 285
Figure 5. Oxygen Polarography and ATP Produc-
tion in MEFs
(A) Respiration rates of MEFs of the indicated genotypes.
Endogenous respiration is the oxygen consumption rate
of untreated cells, and maximal respiration is the oxygen
consumption rate after addition of the uncoupler dinitro-
phenol. Standard deviations from three experiments are
shown.
(B) ATP production via complex I. ATP production was
measured using a luciferase-based assay on 1 3 106
permeabilized cells. Standard deviations from three
experiments are indicated.
(C) Substrate-driven respiration rates of MEFs of the
indicated genotypes. Oxygen consumption rates driven
by the substrates glutamate/malate (complex I), succi-
nate/G3P (complex III), and TMPD/ascorbate (complex
IV) were measured.
Standard deviations from two experiments are shown. In
all panels, single asterisks (p < 0.05) and double asterisks
(p < 0.01) represent significant changes compared to
wild-type. See also Figures S5.error-prone PolgAD257A function. These results underscore the
importance of an intermixing mitochondrial network to amelio-
rate the damaging effects of mtDNA mutations.
DISCUSSION
Our studies provide insight into the in vivo functions of mitochon-
drial fusion in mammals. Mitochondrial fusion plays an essential
role in skeletal muscle fibers, in spite of its compact subcellular
architecture and precise placement of mitochondria. In the
absence of mitochondrial fusion, a pathological profile emerges
that bears striking similarities to human mitochondrial myopa-
thies, particularly those associated with mtDNA depletion
syndromes (Copeland, 2008).
Our studies indicate that mitochondrial fusion safeguards
mtDNA function through three distinct pathways. First, mito-
chondrial dynamics maintains cellular health by stabilizing
mtDNA copy number. In budding yeast, loss of the mitofusin
Fzo1 results in rapid and complete loss of mtDNA (Hermann
et al., 1998; Rapaport et al., 1998), resulting in absence of respi-
ratory function. In contrast, deletion of mammalian mitofusins or
OPA1 results in loss of mtDNA nucleoids from only a subpopula-
tion of mitochondria (Chen et al., 2007). Here, we show that this
unequal distribution of nucleoids is caused, at least in part, by
long-term mtDNA depletion. The dramatic reduction of mtDNA
levels to 7% of wild-type levels at 2 months is likely a key cause
for the mitochondrial myopathy observed in mitofusin-deficient
mice. Consistent with a causative role for mtDNA depletion,
the reduction in mtDNA levels is found prior to overt histological
evidence for muscle fiber dysfunction. Moreover, whereas wild-
type muscle shows a rapid postnatal increase in mtDNA from
weeks 1 to 7, mitofusin-deficient muscle fails to show increased
mtDNA levels (Figure 3), suggesting a possible defect in mtDNA
replication. For comparison, MLC-Cre/Tfam mice—which lack286 Cell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc.a key DNA-binding protein involved in mtDNA packaging,
transcription, and replication—retain greater than 30% mtDNA
levels at 4 months of age (Wredenberg et al., 2002). The
MLC-Cre/dmmice therefore provide an animal model for human
mtDNA depletion syndromes associated with mitochondrial
myopathy (Copeland, 2008). We do not, however, think that
mtDNA depletion solely accounts for the mitochondrial dysfunc-
tion inmutantmuscle; it is likely that the inability tomixmitochon-
drial contents further undermines mitochondrial function.
Second, we discovered that loss of mitochondrial fusion
in skeletal muscle leads to an increase in mtDNA point muta-
tions and deletions. In double-mutant mice, the absolute
levels of mutations are too low to account for the severe physio-
logical defects. For comparison, double-mutant mice have a
several-fold increase in mtDNA point mutations, whereas
PolgAD257A/D257A mutator mice have a 2–3 orders-of-magnitude
increase (Vermulst et al., 2007). In oldMfn1mutant mice, mtDNA
deletion levels are comparable to those of PolgAD257A/D257Amice
(Vermulst et al., 2008a). Although their relationship to the physi-
ological phenotypes is unclear, these substantial increases in
point mutations and deletions demonstrate the importance of
mitochondrial fusion for mtDNA fidelity. It is interesting to note
that some cases of dominant optic atrophy caused by dysfunc-
tion of the mitochondrial fusion gene OPA1 are associated with
respiration-deficient muscle fibers and accumulation of mtDNA
deletions (Amati-Bonneau et al., 2008; Hudson et al., 2008).
This accumulation of mtDNA mutations could be driven by
multiple mechanisms. In principle, the accumulation of mtDNA
mutations can be due to an increase in mtDNA damage, a failure
to repair damaged mtDNA, or perhaps a failure to clear mito-
chondria with damaged mtDNA. Our finding that Mfn-double
null cells have great protein heterogeneity, from one mitochon-
drion to another, provides a plausible mechanism that may
contribute to each of these processes. If protein stoichiometries
are improperly balanced, protein complexes critical for mtDNA
replication, maintenance, repair, and clearance may operate
inefficiently or with lower fidelity. We anticipate that additional
mechanisms leading to mtDNA instability will be uncovered
with future studies.
The demonstration of a link between mitochondrial fusion and
mtDNA fidelity raises the issue of whether mitochondrial fusion
playsaprotective role inconditionsassociatedwithmtDNAmuta-
tions. For instance, age-related neurodegeneration and muscle
atrophy are closely associated with mtDNA mutations (Chomyn
and Attardi, 2003; Krishnan et al., 2007). It will be interesting to
examine whether mitochondrial fusion in humans is a modifying
factor that affects the rate at which mtDNA mutations occur.
Finally, our finding that loss of Mfn1 is incompatible with an
error-prone mtDNA polymerase suggests that mitochondrial
fusion can dramatically dampen the deleterious effects of pre-
existing mtDNA mutations to preserve respiratory function. The
synthetic lethality of mice containing PolgAD257A/D257A and
Mfn1/ mutations indicates that a critical cell type has been
compromised. Previous experiments show that Mfn1 and Mfn2
play largely redundant roles in mitochondrial fusion, and it is
the expression patterns of the two proteins that often dictate
which tissues are selectively affected by the deletion of either
gene (Chen et al., 2003, 2005, 2007). Therefore, the affected cells
in PolgAD257A/D257AMfn1/micemay expressMfn1more highly
than Mfn2. Alternatively, they may be exquisitely sensitive to
changes in mitochondrial function and may be affected by
deletion of either mitofusin.
Our findings may be applicable to the pathogenesis of mito-
chondrial encephalomyopathies caused by mtDNA point muta-
tions and deletions. Such diseases typically show a ‘‘threshold
effect,’’ in that clinical signs manifest only when the level of path-
ogenic mtDNA in a particular cell lineage breaches a critical level
(DiMauro and Schon, 2003; Rossignol et al., 2003). From studies
of patient samples and experimental cybrids, the threshold level
for mtDNA deletions is around 60%, whereas the threshold for
point mutations can be as high as 90% (Rossignol et al., 2003;
Chomyn, 1998; Chomyn et al., 1992). It has been proposed
that protection in the face of mtDNA mutations might result
from the ability of mitochondrial fusion, through content mixing,
to allowmtDNA genomes with distinct mutations to complement
each other (Nakada et al., 2001, 2009). Such complementation
would be possible even if genomeswithin a singlemitochondrion
do not physically interact (Gilkerson et al., 2008). Our results
provide strong experimental support for this hypothesis and
suggest that mitochondrial fusion may ameliorate the clinical
severity of inherited mtDNA encephalomyopathies. In future
work, it will be important to address whether mitochondrial
fusion plays an analogous protective role against age-associ-
atedmtDNA deletions, which similarly cause cellular dysfunction
only upon clonal expansion to high levels (Bender et al., 2006;
Kraytsberg et al., 2006; Wanagat et al., 2001).EXPERIMENTAL PROCEDURES
Mouse Breeding and Physiological Experiments
MLC-Cre/dm mice and littermate controls were bred by crossing MLC-
Cre,Mfn1+/,Mfn2+/ mice to Mfn1loxP/loxP,Mfn2loxP/loxP mice. PolgA,Mfn1animals were generated by crossing PolgAD257A/+,Meox2-Cre,Mfn1+/ mice
to PolgAD257A/+,Mfn1loxP/loxP mice. The Mfn1 mutant (Chen et al., 2003,
2007), Mfn2 mutant (Chen et al., 2003, 2007), PolgAD257A mutant (Kujoth
et al., 2005), MLC-Cre (Bothe et al., 2000), and Meox2-Cre mice (Tallquist
and Soriano, 2000) have been described previously.
Physiological measurements were performed on 7- to 8-week-old mice.
Body temperature was measured with a rectal probe, using the Thermalert
Monitoring Thermometer, TH-5 (Braintree Scientific). Blood glucose levels
were measured using one drop of blood from the tail vein with the OneTouch
Ultra2 Blood Glucose Monitoring System (LifeScan). To obtain lactate
measurements, eye bleeds were performed onmice anesthetized with avertin,
and the blood was analyzed in CG4+ cartridges with the iSTAT system
(Abbott). Mice were exercised by swimming for 20 min at 37C before being
anesthetized. All experiments were approved by the Institutional Animal Care
and Use Committee at Caltech.Histological and EM Analysis
TA muscle was used for histological analysis, as this muscle contains a high
percentage of fast-twitch fibers that expressMLC-Cre. For COX/SDH staining,
freshly dissected muscle was embedded in Optimal Cutting Temperature
(OCT) compound (Tissue-Tek) and frozen in liquid nitrogen. Slides were
stained for COX activity, washed in water, stained for SDH activity, washed,
and mounted in GelMount (Biomeda). Staining protocols were obtained from
the Washington University Neuromuscular Disease Center website (http://
www.neuro.wustl.edu/neuromuscular/index.html).
For EM, mice were perfused with 3% paraformaldehyde, 1.5% glutaralde-
hyde, 100 mM cacodylate (pH 7.4), and 2.5% sucrose. The TA was immobi-
lized in an outstretched position by tying onto a toothpick splint prior to
excision. The splint-attached muscle was postfixed for 1 hr and then pro-
cessed and imaged as described previously (Chen et al., 2007).
For analysis of muscle fiber types, fresh-frozen TA muscle was transversely
cryosectioned and immunostained with mouse IgG1 anti-MHC2A (ATCC
HB-277) or mouse IgM anti-MHC2B (ATCC HB-283). Cy3-sheep anti-mouse
(Jackson ImmunoResearch) or Alexa Fluor 555-goat anti-mouse IgM (Invitro-
gen) were used as secondary antibodies.Cell Culture and Respiration Measurements
Previously established MEFs were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen) supplemented with either 10% fetal bovine serum
(Mfn-double null and OPA1 null cells) or 10% bovine calf serum (wild-type,
Mfn1/, andMfn2/ cells). MEFs for polarography were derived from embry-
onic day (E) 12.5 embryos, infected with a retrovirus expressing SV40 large T
antigen to promote immortalization, and maintained in DMEM, 10% fetal
bovine serum, 1 mM pyruvate, and 50 mg/ml uridine.
Oxygen consumption was measured in intact cells using a Clark oxygen
electrode (Oxygraph, Hansatech Instruments), as described previously
(Chen et al., 2005; Villani and Attardi, 2001). Substrate-driven oxygen
consumption rates were measured essentially as described (Duan et al.,
2003) with the following modifications. The first wash in Respiration buffer I
was omitted, succinate and glycerol-3-phosphate were used to drive respira-
tion through complex III, and N,N,N’,N’-tetramethyl-p-phenyldiamine dihydro-
chloride (TMPD)-driven respiration was measured in Respiration buffer I
instead of Respiration buffer II. The substrate and inhibitor concentrations
were as follows: 5 mM glutamate, 5 mM malate, 200 nM rotenone, 5 mM
succinate, 5 mM glycerol-3-phosphate, 12 nM antimycin, 400 mM TMPD,
and 10 mM ascorbate.
For measurement of ATP production, cells were grown to 80% confluency,
harvested, permeabilized with 50 mg/ml digitonin for 1 min, and resuspended
in reaction buffer (150 mM KCl, 25 mM Tris-HCl, 0.4 mM EDTA, 0.1% BSA,
10 mM potassium phosphate, 0.5 mM MgCl2, and 0.15 mM P1,P5-di(adeno-
sine) pentaphosphate). After addition of 0.25 mM Tris-acetate, 40 nM luciferin,
and 1 mg/ml luciferase, luciferase activity was measured in a Tecan Infinite
M200 luminescence meter with 1 3 106 cells per measurement, in the pres-
ence of 1 mM malate and 1 mM pyruvate, with and without 2 mg/ml rotenone.
The ATP measurements in the presence of rotenone were subtracted to give
ATP production via complex I.Cell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc. 287
Expression of Mfn1 or Mfn2 in MEFs was done via retroviral transduction as
described previously (Chen et al., 2003). Both Mfn constructs overexpress
greater than 10-fold over endogeneous Mfn levels, and exclusive mitochon-
drial localization was found, consistent with previous studies (Chen et al.,
2003, 2005; Detmer and Chan, 2007b).
DNA Isolation
To isolate mitochondrial DNA, cells or tissue were first homogenized and
a mitochondrial fraction was isolated according to previously published proto-
cols (Frezza et al., 2007). Mitochondria were then lysed in the presence of
0.5% SDS and 0.2 mg/ml proteinase K in 10 mM Tris-HCl, 0.15M NaCl, and
0.005M EDTA (Vermulst et al., 2008b). mtDNA was then purified by phenol/
chloroform extraction and ethanol precipitation. Total DNA was isolated using
standard protocols.
mtDNA Quantitation
To quantify the amount of mtDNA present per nuclear genome, we used the
following primers:
mtDNA forward primer, CCTATCACCCTTGCCATCAT;
mtDNA reverse primer, GAGGCTGTTGCTTGTGTGAC.
To quantify nuclear DNA, we used a primer set that detects the Pecam gene
on chromosome 6:
nuclear DNA forward primer, ATGGAAAGCCTGCCATCATG;
nuclear DNA reverse primer, TCCTTGTTGTTCAGCATCAC.
Quantification of relative copy number differences was carried out using
both analysis of the difference in threshold amplification between mtDNA
and nuclear DNA (delta delta C(t) method) and analysis with a standard curve
of a reference template. Both methods provided identical results.
mtDNA Mutation Assays
The randommutation capture assays were performed as previously described
(Vermulst et al., 2008b). Briefly, mtDNAwas digestedwith TaqI for 5 hr, with the
addition of 100 units of TaqI every hour. mtDNA was then diluted in a 96 well
format and probed with primers flanking the TaqI restriction site in order to
detect mtDNA genomes that contain a mutation in the TaqI restriction site.
A second pair of primers was used to determine the amount of mtDNA
genomes that was interrogated. PCR steps were as follows: step 1, 37C for
10 min; step 2, 95C for 10 min; step 3, 95C for 30 s; step 4, 58/60C for
1 min; step 5, 72C for 1.5 min; step 6, go to step three 44 times; step 7,
72C for 4 min; step 8, melting curve from 65C to 95C; step 9, hold at 4C
indefinitely. PCR reactions were carried out in 25 ml reactions using the Brilliant
SYBR-green I master mix (Stratagene), containing 10 pM of forward and
reverse primers and 1 unit of uracil DNA glycosylase. The following primers
were used for DNA amplification:
mtDNA control primer forward, CCTATCACCCTTGCCATCAT;
mtDNA control primer reverse, GAGGCTGTTGCTTGTGTGAC;
mtDNA primer flanking Taq634 forward, ACTCAAAGGACTTGGCGGTA;
mtDNA primer flanking Taq634 reverse, AGCCCATTTCTTCCCATTTC;
mtDNA primer flanking Taq7667 forward, AATTTCATCTGAAGACGTCCT C;
mtDNA primer flanking Taq7667 reverse, AACGCTCTTAGCTTCATAGTGA;
mtDNA deletion forward site 1, CAAGGCCACCACACTCCTAT;
mtDNA deletion reverse site 1, GCTTCCGAATGCTAGGCGTT;
mtDNA deletion forward site 2, ACTGACTTCCAATTAGTAGATTCTG;
mtDNA deletion reverse site 2, GAGAGATTTTATGGGTGTAATGC.
All putative mutations were verified by sequencing and TaqI digestion.
Solexa sequencing was performed at the Caltech Genomics Facility.
Libraries of mtDNAwere constructed according to the manufacturer’s instruc-
tions, and paired-end sequence reads of 75 nucleotides were obtained. To
identify candidate deletions, each sequence read was trimmed to 70 nucleo-
tides, and the 15 nucleotides at each end were mapped using the program
Bowtie to the mouse mtDNA genome. Sequence reads with ends mapping
to separate regions of the mtDNA genome were retrieved as candidate
deletions. With this algorithm, deletions occurring within the central 40 nucle-
otide region of a sequence read could be identified. The candidate deletions
were then manually verified. To minimize the false-positive rate, only deletions
identified by four or more independent reads were included in the analysis.288 Cell 141, 280–289, April 16, 2010 ª2010 Elsevier Inc.SUPPLEMENTAL INFORMATION
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